Bacillus amyloliquefaciens

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Bacillus amyloliquefaciens
DrugBank Accession Number
DB15667
Background

Not Available

Type
Biotech
Groups
Experimental
Synonyms
  • Bacillus amyloliquefaciens
  • Bacillus amyloliquefaciens whole
  • Bacillus amyloliquifaciens whole
  • Bacillus velezensis whole

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Lamwave antimicrobial hand sanitizers gelBacillus amyloliquefaciens (0.03 mg/60mL) + Allantoin (0.03 mg/60mL)GelExtracorporealGuangzhou Youmei Biotechnology Co., Ltd.2020-04-16Not applicableUS flag
Lamwave antimicrobial hand sanitizers gelBacillus amyloliquefaciens (0.25 mg/500mL) + Allantoin (0.25 mg/500mL)GelExtracorporealGuangzhou Youmei Biotechnology Co., Ltd.2020-04-16Not applicableUS flag
Lamwave antimicrobial hand sanitizers gelBacillus amyloliquefaciens (0.05 mg/100mL) + Allantoin (0.05 mg/100mL)GelExtracorporealGuangzhou Youmei Biotechnology Co., Ltd.2020-04-16Not applicableUS flag
Lamwave antimicrobial hand sanitizers gelBacillus amyloliquefaciens (0.15 mg/300mL) + Allantoin (0.15 mg/300mL)GelExtracorporealGuangzhou Youmei Biotechnology Co., Ltd.2020-04-16Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Lamwave antimicrobial hand sanitizers gelBacillus amyloliquefaciens (0.03 mg/60mL) + Allantoin (0.03 mg/60mL)GelExtracorporealGuangzhou Youmei Biotechnology Co., Ltd.2020-04-16Not applicableUS flag
Lamwave antimicrobial hand sanitizers gelBacillus amyloliquefaciens (0.25 mg/500mL) + Allantoin (0.25 mg/500mL)GelExtracorporealGuangzhou Youmei Biotechnology Co., Ltd.2020-04-16Not applicableUS flag
Lamwave antimicrobial hand sanitizers gelBacillus amyloliquefaciens (0.05 mg/100mL) + Allantoin (0.05 mg/100mL)GelExtracorporealGuangzhou Youmei Biotechnology Co., Ltd.2020-04-16Not applicableUS flag
Lamwave antimicrobial hand sanitizers gelBacillus amyloliquefaciens (0.15 mg/300mL) + Allantoin (0.15 mg/300mL)GelExtracorporealGuangzhou Youmei Biotechnology Co., Ltd.2020-04-16Not applicableUS flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
1M5Y26M37U
CAS number
Not Available

References

General References
Not Available
RxNav
2359256
Wikipedia
Bacillus_amyloliquefaciens

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
GelExtracorporeal
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at April 18, 2020 16:02 / Updated at June 12, 2020 16:53